The Food and Drug Administration approved and granted emergency use authorization for the most recent, ...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding the vaccination's reach
The Food and Drug Administration on Friday approved GSKRespiratory syncytial virus vaccine for adults aged ...
The Food and Drug Administration approved on Friday Modern Respiratory syncytial virus vaccine for adults ...
Modern said Friday that the Food and Drug Administration has delayed approval of its respiratory ...